Janus Henderson Group PLC Has $1.87 Million Stock Holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Janus Henderson Group PLC lessened its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 98.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 98,713 shares of the medical instruments supplier's stock after selling 6,291,054 shares during the quarter. Janus Henderson Group PLC's holdings in DENTSPLY SIRONA were worth $1,873,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Colonial Trust Co SC acquired a new position in DENTSPLY SIRONA in the fourth quarter valued at about $26,000. Riverview Trust Co acquired a new position in DENTSPLY SIRONA in the fourth quarter valued at about $26,000. MassMutual Private Wealth & Trust FSB boosted its position in DENTSPLY SIRONA by 648.4% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier's stock valued at $27,000 after buying an additional 1,232 shares in the last quarter. UMB Bank n.a. boosted its position in DENTSPLY SIRONA by 60.8% in the fourth quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier's stock valued at $28,000 after buying an additional 564 shares in the last quarter. Finally, Mitsubishi UFJ Asset Management Co. Ltd. boosted its position in DENTSPLY SIRONA by 700.0% in the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,792 shares of the medical instruments supplier's stock valued at $33,000 after buying an additional 1,568 shares in the last quarter. Institutional investors own 95.70% of the company's stock.

Insider Activity at DENTSPLY SIRONA

In other DENTSPLY SIRONA news, Director Gregory T. Lucier acquired 15,142 shares of the business's stock in a transaction that occurred on Monday, March 3rd. The shares were acquired at an average cost of $16.51 per share, for a total transaction of $249,994.42. Following the completion of the acquisition, the director now directly owns 81,971 shares of the company's stock, valued at approximately $1,353,341.21. This represents a 22.66% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 0.50% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

XRAY has been the topic of a number of recent analyst reports. Mizuho reduced their price target on shares of DENTSPLY SIRONA from $21.00 to $18.00 and set a "neutral" rating on the stock in a research report on Thursday, March 13th. Wells Fargo & Company reduced their price target on shares of DENTSPLY SIRONA from $20.00 to $19.00 and set an "equal weight" rating on the stock in a research report on Friday, February 28th. Robert W. Baird reduced their price target on shares of DENTSPLY SIRONA from $22.00 to $20.00 and set a "neutral" rating on the stock in a research report on Friday, February 28th. Wall Street Zen upgraded shares of DENTSPLY SIRONA from a "hold" rating to a "buy" rating in a research report on Friday, May 9th. Finally, Needham & Company LLC reiterated a "hold" rating on shares of DENTSPLY SIRONA in a research report on Thursday, March 13th. Eleven equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company's stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Hold" and an average target price of $20.36.

DENTSPLY SIRONA Price Performance

Shares of XRAY stock traded up $0.87 during trading hours on Tuesday, reaching $16.34. 2,368,514 shares of the company were exchanged, compared to its average volume of 2,966,347. The stock's fifty day moving average is $14.48 and its two-hundred day moving average is $17.06. DENTSPLY SIRONA Inc. has a fifty-two week low of $12.16 and a fifty-two week high of $28.25. The company has a market cap of $3.26 billion, a price-to-earnings ratio of -7.89, a P/E/G ratio of 1.80 and a beta of 0.92. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last announced its quarterly earnings data on Thursday, May 8th. The medical instruments supplier reported $0.43 earnings per share for the quarter, beating the consensus estimate of $0.29 by $0.14. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The business had revenue of $879.00 million for the quarter, compared to analyst estimates of $854.75 million. During the same period in the prior year, the business posted $0.42 earnings per share. DENTSPLY SIRONA's revenue was down 7.8% compared to the same quarter last year. Sell-side analysts forecast that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current fiscal year.

DENTSPLY SIRONA Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 11th. Investors of record on Friday, June 27th will be issued a $0.16 dividend. This represents a $0.64 annualized dividend and a yield of 3.92%. DENTSPLY SIRONA's dividend payout ratio is currently -14.10%.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.